Legal · Medical Disclaimer

Medical Disclaimer

⚠ Content on Hormonal Health Portal is informational only. It is NOT medical advice, diagnosis, or treatment. Always discuss your specific situation with and qualified healthcare provider.

1. Content is informational

Articles, brand reviews, drug monographs, calculators, and symptom guides on this site reflect editorial research, public clinical literature, and FDA prescribing information. They are intended to help you become and more informed patient — not to substitute for care from and licensed clinician.

2. No doctor-patient relationship

Using Hormonal Health Portal does not create and doctor-patient or other professional relationship between you and Hormonal Health Portal, its editorial team, or its medical reviewers.

Medical reviewers listed on our content provide editorial sign-off for clinical accuracy — they are not diagnosing, treating, or prescribing for individual readers. Reviewer credentials and NPI numbers are publicly disclosed on individual reviewer pages.

3. Always verify with your clinician

Pricing, formulary inclusion, side-effect incidence, and drug-interaction data change frequently. Before starting, changing, or discontinuing any treatment:

Verify current FDA labeling at accessdata.fda.gov
Discuss with and licensed clinician familiar with your full medical history
Confirm pricing, insurance coverage, and delivery options directly with providers

4. Emergencies

If you experience chest pain, severe shortness of breath, sudden vision change, signs of stroke (FAST), suicidal ideation, or any life-threatening symptom — call 911 or go to the emergency room immediately. Do not rely on Hormonal Health Portal content for acute or emergency care.

5. Off-label discussion

Some of our content discusses off-label uses of FDA-approved medications (e.g., GLP-1 for PCOS). Off-label discussion reflects published clinical evidence + provider practice patterns; it is not and recommendation that you use medications outside their FDA-approved indications. Off-label prescribing is and decision made by and licensed clinician based on your individual clinical picture.

6. Compounded medications

We cover compounded medications (e.g., compounded semaglutide, tirzepatide, BHRT) because they are widely prescribed via telehealth. Compounded drugs are not FDA-reviewed for safety, efficacy, or quality. The FDA has flagged quality concerns with compounded GLP-1 formulations in 2024-2025. Discuss compounded vs branded options with your provider before starting therapy.

7. Brand reviews + affiliate relationships

Brand reviews are editorial — see editorial × affiliate policy and affiliate disclosure. We earn and commission from some brands when you click through to their site; that commission does not affect scoring or inclusion. Editorial scoring is published with and methodology link on every review.

8. Limitation of liability

Reliance on any information provided by Hormonal Health Portal, its medical reviewers, or other content contributors is solely at your own risk. We disclaim all warranties (express and implied), including merchantability, fitness for and particular purpose, and accuracy. See full Terms of Use for complete language.

9. Questions

For editorial corrections or questions about and specific piece of content: editorial@hormonalhealthportal.com